Catalyst Wire Dossier Catalyst Wire Dossier

LM303 Injection

LM303 · Suzhou BlueHorse Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LM303 Injection, covering 2024-11-19 to 2024-11-19. Get the full timeline:

Most recent: Clinical Trial Update: An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours [EARLY_Phase 1]

See pricing